Sun, Sep 21, 2014, 12:43 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ALLIQUA, INC. Message Board

  • kennbuck kennbuck Dec 2, 2011 8:38 AM Flag

    Additional Insider trading On Alliqua

    Additional insider Trading on Alliqua stock within the last week.

    On Nov 22, 2011, Harborview Advisors purchased 54,000 shares.

    On Nov 28, 2011, Harborview Advisors again purchased 50,000 shares at $0.10 per share.

    As of November 28, 2011, Harborview Advisors now owns 37,158,498 shares, and this has been steadly being increased.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • As someone in the biotech business, mainly start-up stage microcaps. I have seen this before. The insiders alwasy buy up all they can on open market.
      In time we will see a major anouncement from their clinical trials, and also on the hepa cells research from the tests done on the cells on the international space station.

      Even with out the hepamate, those porcine cells are worth billions. The patent on them are still owned by Alliqua.
      I imagine some science anouncement on them in the future.

      Frost also knows that cell line has promise, but we will see.

      But in all things, one never knows one way or another, just my speculation.

 
ALQA
4.92-0.08(-1.60%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.